A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to conduct blood tests to measure how much LOXO-783 is in
the bloodstream and how the body handles and eliminates LOXO-783 when administered alone or
in combination with cholestyramine in healthy participants. The study will also evaluate the
safety and tolerability of LOXO-783 with and without cholestyramine. Participation could last
up to 63 days including screening period.